Inclusion completed

Pazopanib in advanced gastrointestinal stromal tumors refractory to imatinib and sunutinib. A Non-comparative phase II multicenter study study by the Scandinavian Sarcoma Group

Cancer type: Gastric cancer

Phase: II

Principal Investigator: Joensuu Heikki

Country: FI

Keywords: Gastrointestinal stromal tumor (GIST), Finland

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01524848?term=Scandinavian+Sarcoma+Group&rank=2